search
Mace
Trends
- 1Farewell List Bids Goodbye to Trump, MAGA Allies●Goodbye to: Trump Hegseth ICE Johnson Abbott Boebert Musk Mace GOP MAGA Rogers Putin Russia Melania Gerrymandering Repub
A widely shared post lists dozens of political figures and movements — Donald Trump, Pete Hegseth, Elon Musk, Vladimir Putin, Mike Johnson, Greg Abbott and others — under a single word: 'Goodbye.' The message reads as a celebratory send-off to Trump, his administration, MAGA allies, conservative media figures and Republican priorities such as gerrymandering, drawing enthusiastic engagement from critics of the current US administration.
- 2
Mace Construct, the construction business carved out of the Mace Group, has reported a £62 million pre-tax loss for its carve-out year. The result, disclosed on the group's projects site, points to significant financial strain during the separation process, prompting discussion about the carve-out's cost and the outlook for the restructured business.
- 3
Ottawa Senators forward Zack MacEwen is in the news following his post-game appearance after a matchup against the New York Rangers on October 22, 2026. Coverage of his media availability is running alongside broader NHL discussion, including a survey finding most Canadian fans dislike subscription creep in league broadcasting.
- 4Inovio Pharmaceuticals Stock Draws Investor Attention▼Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History
Inovio Pharmaceuticals (NASDAQ: INO) is seeing renewed attention on financial platforms, with its stock price, quotes, and historical performance being tracked by investors. The biotech company, known for developing DNA-based immunotherapies and vaccines, remains on watchlists as traders look for updates on its clinical pipeline and financial position. No specific new development was cited in the coverage.
- 5
A 21-year-old man, identified locally as Stefano Fiori, died after losing control of his BMW and crashing into a wall along the Settempedana road near San Severino Marche, in the province of Macerata. Local outlets report he had loved motors since childhood. The fatal crash and a major fraud investigation into post-2016 earthquake reconstruction in the Marche, with 51 suspects and 57 million euros seized, are driving regional news interest.
- 6OPIDIGON releases Q4 year end documentation●OPIDIGON PUBLIC NOTICE PUBLIC NOTICE Date: October 29, 2026 From: OPIDIGON Pharmaceutical Phytochemistry & Bioengineerin
OPIDIGON Pharmaceutical Phytochemistry & Bioengineering issued a public notice dated October 29, 2026, announcing that its Q4 year end documentation is now officially available. The notice was published on the company's WordPress page and confirms the release of its fourth-quarter information package. Beyond the announcement itself, no further details about the contents of the documentation or reactions to it are included in the notice.
- 7North Korea condemns US-South Korea Ironmace drill, vows nuclear buildup▼North Korea slams South Korea–US Ironmace drill, vows stronger nuclear deterrent
North Korea has denounced the joint South Korea-US military exercise known as Iron Mace, calling it a provocation and vowing to further strengthen its nuclear deterrent in response. The drill, involving US and South Korean forces, has drawn sharp criticism from Pyongyang, which routinely frames joint exercises as rehearsal for invasion and uses them to justify weapons development.
- 8North Korea condemns Iron Mace drills, vows nuclear buildup▼N. Korea blasts Iron Mace drills, vows to accelerate nuclear deterrence
North Korea has denounced the Iron Mace military exercises and declared it will speed up efforts to expand its nuclear deterrence. The statement follows joint drills involving South Korean and US forces, which Pyongyang routinely brands as provocation. Analysts say the rhetoric fits a pattern of sharp responses to allied training, warning that continued weapons development could raise tensions on the Korean Peninsula.
- 9North Korea Vows Stronger Nuclear Force, Protests US-South Korea Drill▼N. Korea Vows to 'Control Wicked Enemies' with Stronger Nuclear Force, Protests S. Korea-US 'Iron Mace' Drill
North Korea has declared it will 'control wicked enemies' with a strengthened nuclear force, while formally protesting the 'Iron Mace' joint military exercise conducted by South Korea and the United States. The statement follows Pyongyang's long-standing pattern of condemning allied drills as rehearsal for invasion. Observers are watching whether the rhetoric signals further weapons tests or a tougher stance in ongoing regional tensions.
- 10AbbVie signs $757m migraine drug deal with Brise Pharmaceuticals●AbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals
AbbVie has agreed a deal worth up to $757m with Brise Pharmaceuticals focused on migraine treatments. The agreement covers development work in a field where AbbVie already markets major therapies, including Botox for chronic migraine and the CGRP blocker Qulipta. Financial details beyond the headline value were not disclosed in initial reports, and the specific assets involved have not yet been named publicly.
- 11North Korea Denounces Iron Mace Drills as Nuclear War Rehearsal▼N. Korea slams Iron Mace drills as 'most vicious nuclear war rehearsal'
North Korea has condemned the Iron Mace military exercises, calling them the most vicious rehearsal for nuclear war. The statement intensifies tensions on the Korean Peninsula, where joint drills by South Korean and allied forces continue to draw sharp rhetoric from Pyongyang, which routinely portrays such exercises as preparation for invasion.
- 12Napo Pharmaceuticals panel on crofelemer at Dubai pediatric gastroenterology conference●CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
The chief scientific officer of Napo Pharmaceuticals, a Jaguar Health company, joined clinical investigators studying the drug crofelemer for a panel discussion at a pediatric gastroenterology conference in Dubai, United Arab Emirates. The discussion focused on the company's ongoing evaluation of crofelemer and drew attention to the drug's potential role in pediatric gastrointestinal care.
- 13Traders Watch Pfizer, Inovio, SpaceX, Nvidia and Micron●$Pfizer (PFE.US)$$Inovio Pharmaceuticals (INO.US)$$SpaceX (SPCX.US)$$NVIDIA (NVDA.US)$$Micron Technology (MU.US)$
A bundle of tickers spanning pharma, space and semiconductors is circulating among market watchers, covering Pfizer, Inovio Pharmaceuticals, SpaceX, Nvidia and Micron Technology. The mix points to investors tracking healthcare, chip and commercial space names side by side, though no specific move or news event is attached to the listing itself.
- 14Jazz Pharmaceuticals Q3 earnings preview●What to expect from Jazz Pharmaceuticals’s (JAZZ) Q3 earnings
Investors are looking ahead to Jazz Pharmaceuticals' third-quarter earnings report. Analysts and market watchers are weighing expectations for the drugmaker's revenue and profit, with attention on sales of its key therapies, including epilepsy and sleep disorder treatments, and how results may shape the company's outlook for the rest of the year.
- 15Nancy Mace Introduces Bill to Ban Synthetic Dyes▼Rep. Nancy Mace Introduces Bill to Ban Synthetic Dyes from America's Food, Medicine, and Cosmetics
Representative Nancy Mace has introduced legislation that would ban synthetic dyes from food, medicine, and cosmetics sold in the United States. The bill, announced through her congressional office, targets artificial color additives widely used in consumer products. It aligns with a broader push by lawmakers and health officials to restrict petroleum-based dyes over health concerns.
- 16Telix Pharmaceuticals stock draws investor attention●Telix Pharmaceuticals Limited (TLX) stock price, news, quote and history
Telix Pharmaceuticals Limited (TLX), the Australia-based radiopharmaceutical company, is seeing heightened interest in its stock price, quotes and trading history as investors look up the latest news on the company. No specific corporate development is attached to the surge in searches, but the biotech has been a regular subject of market coverage given its pipeline of imaging and therapeutic candidates.
- 17AstraZeneca Shares Jump Over 6% After Earnings as Pharma Stocks Rally●US Stock Market Movements | Pharmaceutical Stocks Continue Rally; AstraZeneca (AZN.US) Surges Over 6% Post-Earnings
AstraZeneca shares surged more than 6% in US trading after the company reported earnings, leading a continued rally in pharmaceutical stocks. The gains made the drugmaker one of the standout movers of the session, with investors rewarding results that beat expectations and fueling broader optimism across the pharma sector.
- 18Alnylam Pharmaceuticals Reports Third Quarter 2026 Results●Alnylam Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Period Progress
Alnylam Pharmaceuticals has released its financial results for the third quarter of 2026, alongside an update on progress made in its recent period. The RNA interference therapeutics company disclosed quarterly performance figures and highlighted developments across its business. Further details on revenue, pipeline milestones and guidance were included in the company's announcement to investors.